Huang_2024_Drug.Des.Devel.Ther_18_133

Reference

Title : In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease - Huang_2024_Drug.Des.Devel.Ther_18_133
Author(s) : Huang ST , Luo JC , Zhong GH , Teng LP , Yang CY , Tang CL , Jing L , Zhou ZB , Liu J , Jiang N
Ref : Drug Des Devel Ther , 18 :133 , 2024
Abstract : Huang_2024_Drug.Des.Devel.Ther_18_133
ESTHER : Huang_2024_Drug.Des.Devel.Ther_18_133
PubMedSearch : Huang_2024_Drug.Des.Devel.Ther_18_133
PubMedID: 38283137

Related information

Citations formats

Huang ST, Luo JC, Zhong GH, Teng LP, Yang CY, Tang CL, Jing L, Zhou ZB, Liu J, Jiang N (2024)
In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer's Disease
Drug Des Devel Ther 18 :133

Huang ST, Luo JC, Zhong GH, Teng LP, Yang CY, Tang CL, Jing L, Zhou ZB, Liu J, Jiang N (2024)
Drug Des Devel Ther 18 :133